Ver Investigador - - Prisma - Unidad de Bibliometría

Ana Belen Garcia Delgado

Acceso Margarita Salas (USE)
agarcia23@us.es
Área de conocimiento: Farmacia y Tecnología Farmacéutica
Departamento: Farmacia y Tecnología Farmacéutica
Grupo: Investigación y Desarrollo Tecnológico en Nanomedicina - CTS-480 (Universidad de Sevilla)

Investiga en

Tipo Año Título Fuente
Capítulo2024 Internacionalización de un máster de posgrado en terapias avanzadas Enseñanza e innovación educativa en el ámbito universitario
Artículo2023 Bioengineered tissue and cell therapy products are efficiently cryopreserved with pathogen-inactivated human platelet lysate-based solutions Stem cell research & therapy
Póster2023 Preclinical evaluation of the safety and potency of neural stem cells from the germinal zone (Gz-NSC) for the treatment of intraventricular hemorrhage (IVH) consequences. Biosaia
Resumen congreso2023 USING ORGANOIDS TO EVALUATE THE SAFETY AND EFFICACY PROFILE OF CELL THERAPEUTICS CYTOTHERAPY
Artículo2022 Brain organoids to evaluate cellular therapies Animals
Revisión2021 Dissecting the role of EYS in retinal degeneration: clinical and molecular aspects and its implications for future therapy ORPHANET JOURNAL OF RARE DISEASES
Artículo2021 Generation of the human iPSC line ESi082-A from a patient with macular dystrophy associated to mutations in the CRB1 gene STEM CELL RESEARCH
Revisión2021 Human neural stem cells for cell-based medicinal products Cells
Póster2019 'Ex vivo' gene correction of PRPF31 c.165G>A mutation causing retinitis pigmentosa Biosaia
Editorial2019 Generation and characterization of the human iPSC line CABi001-A from a patient with retinitis pigmentosa caused by a novel mutation in PRPF31 gene STEM CELL RESEARCH
Editorial2019 Generation of a human iPS cell line (CABi003-A) from a patient with age-related macular degeneration carrying the CFH Y402H polymorphism STEM CELL RESEARCH
Artículo2019 Retinal pigment epithelium degeneration caused by aggregation of PRPF31 and the role of HSP70 family of proteins MOLECULAR MEDICINE
Artículo2019 Subretinal Transplant of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium on Nanostructured Fibrin-Agarose TISSUE ENGINEERING PART A
Artículo2019 The Resveratrol Prodrug JC19 Delays Retinal Degeneration in rd10 Mice Advances in experimental medicine and biology
Editorial2018 Generation of a human iPS cell line from a patient with retinitis pigmentosa due to EYS mutation STEM CELL RESEARCH
Artículo2018 Rasagiline delays retinal degeneration in a mouse model of retinitis pigmentosa via modulation of Bax/Bcl-2 expression CNS NEUROSCIENCE & THERAPEUTICS
Artículo2016 Span poly-L-arginine nanoparticles are efficient non-viral vectors for PRPF31 gene delivery: An approach of gene therapy to treat retinitis pigmentosa NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
Artículo2015 Human iPSC derived disease model of MERTK-associated retinitis pigmentosa Scientific reports
Póster2014 Modelo celular de retinitis pigmentaria basado en células de pluripotencia inducida Biosaia
Terapias avanzadas para enfermedades degenerativas de la retina (2021)
Dirigida por: Bhattacharya, Shomi, Díaz Corrales, Francisco Javier

Este investigador no ha dirigido/tutorizado tesis
El investigador no tiene ningún proyecto asociado.
El investigador no tiene ningún resultado de investigación asociado